# Duloxetine for Major Depression in Peri-/Postmenopausal Women

> **NCT00889369** · PHASE4 · UNKNOWN · sponsor: **Hamilton Health Sciences Corporation** · enrollment: 70 (estimated)

## Conditions studied

- Major Depressive Disorder

## Interventions

- **DRUG:** Duloxetine

## Key facts

- **NCT ID:** NCT00889369
- **Lead sponsor:** Hamilton Health Sciences Corporation
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2009-05
- **Primary completion:** 2012-02
- **Final completion:** 2012-06
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2012-02-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00889369

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00889369, "Duloxetine for Major Depression in Peri-/Postmenopausal Women". Retrieved via AI Analytics 2026-07-01 from https://api.ai-analytics.org/clinical/NCT00889369. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*